CervoMed receives US patent allowance for neflamapimod use in Lewy body dementia
CervoMed receives US patent allowance for neflamapimod use in Lewy body dementia
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
CervoMed receives US patent allowance for neflamapimod use in Lewy body dementia